Sense Biodetection

Sherlock Biosciences is pioneering advancements in molecular diagnostics by leveraging CRISPR and synthetic biology technologies. The company's proprietary platforms, such as the CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™, are designed to enable rapid, accurate, and affordable DNA and RNA detection. These tools are meant for diverse settings, from clinical laboratories to point-of-need locations, promoting the decentralization and democratization of healthcare. Sherlock Biosciences is committed to revolutionizing healthcare by providing consumers with the ability to make informed health decisions through accessible diagnostic tests. The team comprises experts with extensive experience in CRISPR and Synthetic Biology, driving innovations that aim to disrupt traditional healthcare paradigms and enhance global health outcomes.